Ratings Bastide Le Confort Médical

Equities

BLC

FR0000035370

Real-time Euronext Paris 11:35:12 2024-04-30 am EDT 5-day change 1st Jan Change
18 EUR -1.10% Intraday chart for Bastide Le Confort Médical +14.21% -32.84%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • Its low valuation, with P/E ratio at 7.88 and 5.77 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • With regards to fundamentals, the enterprise value to sales ratio is at 0.89 for the current period. Therefore, the company is undervalued.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company does not generate enough profits, which is an alarming weak point.
  • The company is in debt and has limited leeway for investment
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
-32.84% 143M -
-3.17% 3.01B
B-
-.--% 1.83B -
+3.55% 1.55B
C
+50.22% 628M
D+
-2.51% 506M -
-39.53% 345M -
-11.23% 140M -
+5.77% 70.32M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. BLC Stock
  4. Ratings Bastide Le Confort Médical